基本信息
views: 891

Bio
My research aims to invent and develop novel biomimetic nanotechnologies for various biomedical applications with a particular focus on drug delivery, biological neutralization, and vaccination. The major goal is to address significant challenges in the treatment and prevention of serious infectious diseases, inflammatory and autoimmune diseases, and cancers through research discovery and entrepreneurial translation.
Research Interests
Papers共 390 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Frontiers in Immunology (2025)
Small methodspp.e2500624-e2500624, (2025)
Nishta Krishnan,Jiarong Zhou,Animesh Mohapatra, Christian John Ventura,Yaou Duan, Junyong Lee, Jacob J Hoenig, Oliver Nizet,Weiwei Gao,Ronnie H Fang,Liangfang Zhang
Advanced materials (Deerfield Beach, Fla)no. 14 (2025): e2501616-e2501616
ADVANCED HEALTHCARE MATERIALSno. 2 (2025)
Zhengxing Li,Zhongyuan Guo, Fangyu Zhang,Lei Sun,Hao Luan, Zheng Fang,Jeramy L. Dedrick, Yichen Zhang, Christine Tang, Audrey Zhu,Yiyan Yu,Shichao Ding,Dan Wang,An-Yi Chang,Lu Yin,Lynn M. Russell,Weiwei Gao,Ronnie H. Fang,Liangfang Zhang,Joseph Wang
Trends in biotechnology (2025)
JOURNAL OF CONTROLLED RELEASE (2025): 145-152
Lei Sun, Kailin Feng, Dean Bai,Yiyan Yu,Wei-Ting Shen,Jiayuan Alex Zhang,Ronnie H Fang,Weiwei Gao,Liangfang Zhang
Biomaterials (2025): 123188-123188
Kailin Feng,Jiayuan Alex Zhang,Wei-Ting Shen, Tianle Leng, Zhidong Zhou,Yiyan Yu,Weiwei Gao,Liangfang Zhang
Bioactive Materials (2024): 321-330
Load More
Author Statistics
#Papers: 389
#Citation: 52878
H-Index: 123
G-Index: 227
Sociability: 8
Diversity: 4
Activity: 237
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn